Tabrecta ATC Classification

capmatinib

Manufacturer:

Novartis

Distributor:

Zuellig

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Patient Counseling Information MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

ATC Classification

L01EP01 - capmatinib ; Belongs to the class of cellular-mesenchymal-epithelial transition factor (c-MET) kinase inhibitors. Used in the treatment of cancer.

Continue with Google

Already a member? Sign In